- Published on
Emergency and Acute Medicine – Toluene Poisoning
Toluene poisoning results from exposure to a volatile hydrocarbon that is a clear, colorless liquid with a characteristic sweet odor. It is widely used as an organic solvent in products such as paints, thinners, glues, inks, correction fluid, petroleum products, and aerosolized household items. Exposure may occur occupationally or through intentional abuse, particularly among adolescents due to its low cost and easy accessibility. Methods of abuse include sniffing directly from a container, huffing vapors from a soaked cloth, and bagging vapors in a confined space for inhalation.
Toluene is rapidly absorbed through inhalation and readily crosses the blood–brain barrier, achieving high concentrations in the brain. It exerts multiple toxic effects, including central nervous system depression, myocardial sensitization to catecholamines, and disruption of cardiac ion channels, predisposing to dangerous dysrhythmias. It is metabolized in the liver and excreted through the lungs and urine. Toxicity is dose-dependent, ranging from mild impairment at lower concentrations to anesthesia, seizures, and death at very high levels.
Clinically, acute toxicity primarily affects the neurologic, cardiac, pulmonary, and metabolic systems. Patients may present with euphoria, dizziness, ataxia, confusion, or seizures. Cardiac effects are particularly dangerous and include potentially fatal dysrhythmias, especially in the setting of catecholamine surges (“sudden sniffing death”). Pulmonary complications include chemical pneumonitis and pulmonary edema. Metabolic abnormalities are characteristic and include hypokalemia, hypocalcemia, and a hyperchloremic metabolic acidosis due to accumulation of hippuric acid. Gastrointestinal symptoms such as nausea, vomiting, and abdominal pain may occur, and renal effects include distal renal tubular acidosis, hematuria, and proteinuria.
Chronic exposure leads to progressive and often irreversible damage. Neurologic complications include peripheral neuropathy, leukoencephalopathy, cerebellar dysfunction, and cognitive impairment. Cardiac complications may include dilated cardiomyopathy and persistent dysrhythmias. Renal injury may progress to chronic failure, and musculoskeletal complications such as rhabdomyolysis can occur. Chronic abuse is also associated with psychiatric issues and addiction. In pregnancy, chronic exposure has been linked to fetal solvent syndrome, resembling fetal alcohol syndrome with growth restriction and developmental delay.
Diagnosis is primarily clinical, supported by history of exposure and physical findings such as solvent odor, perioral dermatitis, or evidence of inhalant use on clothing or skin. Laboratory evaluation typically reveals electrolyte abnormalities, particularly hypokalemia and metabolic acidosis. Renal function tests, creatine kinase (if rhabdomyolysis is suspected), and liver function tests should be obtained. Urinary hippuric acid may confirm exposure but does not correlate with severity. Imaging studies include ECG to detect dysrhythmias and chest radiography if respiratory symptoms are present.
Management focuses on supportive care and stabilization. Initial priorities include airway, breathing, and circulation, with supplemental oxygen, cardiac monitoring, and intravenous fluids. Sudden cardiac death is a major risk due to myocardial sensitization, so careful monitoring is essential. Dysrhythmias should be treated according to standard protocols, with consideration of β-blockers for tachydysrhythmias. Respiratory status should be monitored closely, and chemical pneumonitis is managed supportively, as steroids are not recommended.
Metabolic abnormalities should be corrected, including cautious repletion of potassium, calcium, and phosphate. Acidosis generally improves with fluid resuscitation. In cases of rhabdomyolysis, aggressive hydration is required to maintain urine output. Gastrointestinal decontamination is generally not useful and may increase the risk of aspiration; activated charcoal is ineffective for hydrocarbons.
Disposition depends on clinical severity. Patients with altered mental status, dysrhythmias, significant metabolic disturbances, renal failure, or rhabdomyolysis require admission. Those who return to baseline mental status and remain stable after 4–6 hours of observation without evidence of complications may be discharged.
Key clinical pearls include the risk of sudden death due to catecholamine-induced dysrhythmias and the importance of monitoring and correcting electrolyte abnormalities. Cardiac complications carry a poor prognosis, and cessation of exposure is the most important long-term intervention. Referral for psychiatric evaluation and substance abuse counseling is essential in cases of intentional or repeated use.
0 Comments
